Heme reversibly damps PERIOD2 rhythms in mouse suprachiasmatic nucleus explants.
The hypothalamic suprachiasmatic nucleus (SCN), which in mammals serves as the master circadian pacemaker by synchronizing autonomous clocks in peripheral tissues, is composed of coupled single-cell oscillators that are driven by interlocking positive/negative transcriptional/translational feedback loops. Several studies have suggested that heme, a common prosthetic group that is synthesized and degraded in a circadian manner in the SCN, may modulate the function of several feedback loop components, including the REV-ERB nuclear receptors and PERIOD2 (PER2). We found that ferric heme (hemin, 3-100 microM) dose-dependently and reversibly damped luminescence rhythms in SCN explants from mice expressing a PER2::LUCIFERASE (PER2::LUC) fusion protein. Inhibitors of heme oxygenases (HOs, which degrade heme to biliverdin, carbon monoxide, and iron) mimicked heme's effects on PER2 rhythms. In contrast, heme and HO inhibition did not damp luminescence rhythms in thymus and esophagus explants and had only a small effect on PER2::LUC damping in spleen explants, suggesting that heme's effects are tissue-specific. Analysis of the effects of heme's degradation products on SCN PER2::LUC rhythms indicated that they probably were not responsible for heme's effects on rhythms. The heme synthesis inhibitor N-methylprotoporphyrinIX (NMP) lengthened the circadian period of SCN PER2::LUC rhythms by about an hour. These data are consistent with an important role for heme in the circadian system.
Guenthner
C J
CJ
Department of Psychology and Program in Neuroscience, Smith College, Clark Science Center, 44 College Lane, Northampton, MA 01063, USA.
Bickar
D
D
Harrington
M E
ME
D000818:Animals; D002491:Central Nervous System Agents / Q000494:pharmacology; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology; D004947:Esophagus / Q000502:physiology; D005260:Female; D055879:Gene Knock-In Techniques; D006418:Heme / Q000378:metabolism*; D006419:Heme Oxygenase (Decyclizing) / Q000037:antagonists & inhibitors / Q000378:metabolism; D006427:Hemin / Q000378:metabolism; D066298:In Vitro Techniques; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D056950:Period Circadian Proteins / Q000235:genetics / Q000378:metabolism*; D010507:Periodicity; D011524:Protoporphyrins / Q000494:pharmacology; D013154:Spleen / Q000502:physiology; D013493:Suprachiasmatic Nucleus / Q000187:drug effects / Q000502:physiology*; D013950:Thymus Gland / Q000502:physiology
D002491:Central Nervous System Agents; C513312:Per2 protein, mouse; D056950:Period Circadian Proteins; D011524:Protoporphyrins; D006418:Heme; D006427:Hemin; C028842:N-methylprotoporphyrin IX; D008156:Luciferases; D006419:Heme Oxygenase (Decyclizing)
Free Radic Biol Med. 1996;21(6):763-9
8902522
J Neurosci. 2005 Aug 17;25(33):7682-6
16107654
Science. 2007 Dec 14;318(5857):1786-9
18006707
Exp Neurol. 2001 Oct;171(2):293-300
11573981
Trends Pharmacol Sci. 1997 Jun;18(6):193-5
9226997
Nat Neurosci. 2005 Mar;8(3):267-9
15746913
Biochem Biophys Res Commun. 2008 Apr 18;368(4):955-8
18280802
Mol Cell Biol. 2008 Aug;28(15):4697-711
18505821
Kidney Int. 2007 Oct;72(8):945-53
17667987
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R271-7
16987893
J Pharmacol Exp Ther. 2006 Oct;319(1):277-84
16807364
Cell. 2002 Jul 26;110(2):251-60
12150932
Biol Res. 2006;39(1):189-90
16629179
Cell. 2000 Dec 22;103(7):1009-17
11163178
Science. 2009 May 8;324(5928):804-7
19423828
PLoS Biol. 2007 Feb;5(2):e34
17298173
J Neurosci. 2009 Feb 11;29(6):1670-6
19211874
Science. 2003 Nov 21;302(5649):1408-12
14631044
Neuron. 1995 Apr;14(4):697-706
7718233
Cell. 2007 May 4;129(3):605-16
17482552
Science. 2002 Dec 20;298(5602):2385-7
12446832
J Biol Chem. 2007 Jul 13;282(28):20221-9
17502383
Curr Biol. 2008 Sep 9;18(17):R805-R815
18786386
Nat Struct Mol Biol. 2007 Dec;14(12):1207-13
18037887
J Neurosci Res. 2003 Jul 1;73(1):113-21
12815715
Toxicology. 1998 Feb 6;125(2-3):95-105
9570325
Sleep Med. 2007 Sep;8(6):623-36
17383938
PLoS Genet. 2008 Feb 29;4(2):e1000023
18454201
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14807-12
12417755
PLoS Biol. 2009 Feb 24;7(2):e43
19243223
Nat Cell Biol. 2008 Oct;10(10):1154-63
18806789
BMC Neurosci. 2002;3:1
11825337
Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12843-8
17646651
Neuron. 2004 Aug 19;43(4):527-37
15312651
Nature. 2004 Jul 22;430(6998):467-71
15269772
Science. 2008 May 16;320(5878):949-53
18487196
IUBMB Life. 2005 Apr-May;57(4-5):315-22
16036616
Nat Neurosci. 2006 Aug;9(8):1041-9
16845385
Brain Res. 2008 Sep 26;1232:104-12
18703032
Nature. 2003 Oct 2;425(6957):531-5
14523450
Trends Neurosci. 2001 Feb;24(2):99-106
11164940
J Mol Endocrinol. 2004 Dec;33(3):585-608
15591021
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5339-46
14963227
Proc Natl Acad Sci U S A. 1981 Oct;78(10):6466-70
6947237
J Neurosci. 2008 Apr 30;28(18):4619-23
18448638
Neurosci Lett. 2003 Dec 15;353(1):9-12
14642425
Cell. 2001 Jun 1;105(5):683-94
11389837
Neuron. 2003 Apr 24;38(2):253-63
12718859
J Biol Rhythms. 2005 Oct;20(5):391-403
16267379
Neuroreport. 2009 Jan 28;20(2):213-7
19057417
Pharmacol Rev. 2003 Sep;55(3):551-71
12869663
Neurosci Lett. 2009 Sep 25;461(3):302-5
19539709
J Surg Res. 2008 Mar;145(1):5-12
18279697
Am J Physiol Lung Cell Mol Physiol. 2000 Dec;279(6):L1005-28
11076791